Alx Oncology Holdings Inc (ALXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 18,033 | 18,966 | 23,021 | 22,532 | 26,648 |
| Operating Income | -18,033 | -18,966 | -23,021 | -22,532 | -26,648 |
| Interest Expense | 285 | 331 | 383 | 408 | 405 |
| Other Income | 347 | 1,370 | 556 | 796 | 1,104 |
| Pre-tax Income | -17,971 | -17,927 | -22,848 | -22,144 | -25,949 |
| Net Income Continuous | -17,971 | -17,927 | -22,848 | -22,144 | -25,949 |
| Net Income | $-17,971 | $-17,927 | $-22,848 | $-22,144 | $-25,949 |
| EPS Basic Total Ops | -0.13 | -0.17 | -0.42 | -0.41 | -0.49 |
| EPS Basic Continuous Ops | -0.13 | -0.17 | -0.42 | -0.41 | -0.49 |
| EPS Diluted Total Ops | -0.13 | -0.17 | -0.42 | -0.41 | -0.49 |
| EPS Diluted Continuous Ops | -0.13 | -0.17 | -0.42 | -0.41 | -0.49 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.17 | -0.42 | -0.41 | -0.49 |
| EBITDA(a) | $-18,222 | $-18,947 | $-22,984 | $-22,526 | $-26,699 |